logo
Merz Aesthetics ® Receives Approval from Health Canada for RADIESSE ® as an Aesthetic Injectable for the Treatment of Moderate Wrinkles in the Décolleté Area

Merz Aesthetics ® Receives Approval from Health Canada for RADIESSE ® as an Aesthetic Injectable for the Treatment of Moderate Wrinkles in the Décolleté Area

Business Wirea day ago

BURLINGTON, Ontario--(BUSINESS WIRE)--Merz Aesthetics ® Canada announced today the Health Canada approval for Radiesse ® for the treatment of moderate wrinkles in the décolleté area. Radiesse ® is a regenerative biostimulator 1 capable of regenerating multiple components of the skin tissue, resulting in healthier-looking skin, 1,4,5 and is now approved for use in the décolleté area, adding to the product's versatility.
This new regulatory milestone directly answers patient demand, given there is a significant shift toward regenerative biostimulation.
"Despite being one of the most visible areas of our bodies, the décolleté area is often overlooked when it comes to aesthetics," says Dr. Samantha Kerr, Chief Scientific Officer, Merz Aesthetics ®."Radiesse ® presents a unique solution to improving décolleté wrinkles and provides our customers and their patients a non-surgical, effective option to address aging décolleté skin.'
According to the International Society of Aesthetic Plastic Surgery (ISAPS), non-surgical procedures/minimally invasive treatments between 2018 and 2022 involving calcium hydroxylapatite increased by 171.8% globally between 2018 and 2022. 2
This approval was supported by a large, multicentre clinical trial 3,5,1 which supported the décolleté approval and has provided substantial evidence of the effectiveness of Radiesse ®, demonstrating a significant improvement in the appearance of moderate décolleté wrinkles. 3
" The décolleté is notoriously difficult to treat. Skin in this area is thin, chronically sun-exposed, low in sebaceous glands, prone to accelerated loss of elasticity, and tends to form more complex scars than other regions. Health Canada's new approval of Radiesse® for this area is therefore exciting and welcome news. It is a true biostimulator that has almost 20 years of safety data for the face, and an agent we turn to regularly in our clinic for this area. So, it is great to be able to officially use this amazing product on the décolleté as well. The biostimulatory effects work by triggering collagen, elastin, and micro-vasculature renewal, thickening the tissue and softening lines. It is a powerful treatment that gives natural-looking radiant results. This new approval now gives us a proven, regenerative tool to rejuvenate the skin on the chest," says Dr. Dusan Sajic, a leading Canadian medical and cosmetic dermatologist.
This year Radiesse ® celebrates its 20 th anniversary, having sold more than 15 million syringes globally since 2005. 3 Merz Aesthetics demonstrates a longstanding legacy and commitment to scientific innovation in the aesthetics field. 3
After two decades on the market, the new décolleté indication allows practitioners more versatility to expand the treatment spectrum from the face and hands to treatments for the décolleté. Additionally, the 1:2 dilution with 0.9% sterile saline increases the product adaptability allowing for personalized treatment to address patient needs.
"This new indication for Radiesse ® to treat the décolleté area marks a significant milestone for the aesthetics market," says Chris Van Dyk, Country Manager, Canada, Merz Aesthetics ®. "It not only expands the versatility of Radiesse ® but also addresses a growing patient demand for regenerative aesthetic solutions. By offering a proven, effective treatment for décolleté wrinkles, we are enhancing our commitment to innovation and patient care. This approval underscores our dedication to providing advanced, minimally invasive options that cater to the evolving needs of our patients."
Even in the current landscape, findings from Medical Insight's 2024 Global Aesthetic Market Study suggest that Radiesse ® has emerged as a category leader. 6 This success is backed by over two decades of scientific data and clinical experience by Merz Aesthetics ®, 4,2 with 250 publications, 3 and availability in over 85 countries. 3
About Merz Aesthetics ®
Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients, and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient's needs with high standards of safety and efficacy. Being family owned for more than 115 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics' global headquarters is in Raleigh, N.C., USA, with a commercial presence in 90 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more at merzaesthetics.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Melanoma Canada mobile skin cancer screening unit coming to Burlington, Brampton, Oakville
Melanoma Canada mobile skin cancer screening unit coming to Burlington, Brampton, Oakville

Hamilton Spectator

time34 minutes ago

  • Hamilton Spectator

Melanoma Canada mobile skin cancer screening unit coming to Burlington, Brampton, Oakville

Melanoma Canada is bringing the Mole Mobile skin cancer screening unit on wheels to Burlington, Brampton and Oakville Friday through Sunday. The Mole Mobile is visiting major Canadian cities that have long wait times to see a dermatologist, and underserved communities, to help speed up diagnosis. The screening unit on wheels is open to the public for free skin cancer screenings by certified Canadian dermatologists, and no appointments are necessary. According to a press release from Melanoma Canada, skin cancer is the most common cancer in Canada, yet access to dermatologists remains a challenge. With two Mole Mobile units hitting the road in 2025, the project is expanding its reach and breaking down barriers to early detection. For more information on the Burlington, Brampton and Oakville Mole Mobile cancer screening unit stops and other Ontario stops, see a schedule on the project's website . For additional information, visit the Melanoma Canada website . Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .

Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader
Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader

Business Wire

timean hour ago

  • Business Wire

Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader

AURORA, Ill.--(BUSINESS WIRE)-- Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, proudly announces that its flagship platform, Benefits1™.Medicare, played a key role once again in streamlining over 30% of Medicare Advantage (MA) Plan Benefit Package (PBP) submissions to the Centers for Medicare & Medicaid Services (CMS) this year. This milestone highlights the platform's transformative impact on benefit plan management and its integral role in supporting Payers across the nation. Benefits1™.Medicare continues to be the industry leader, enabling large-scale CMS bid submissions successfully for over 7 years, while also importing data seamlessly from the CMS-PBP software. Designed to handle the complexities of bid submission and accessible immediately (benefit updates can be started at any time independent of HPMS releases), the platform continues to set the standard for speed, accuracy, and compliance in PBP submissions with its seamless integration, robust reporting, global data updates, secure user roles, workflow automation and audit tracking capabilities. 'Our customers relied on Benefits1™.Medicare to streamline over 30% of nationwide PBP submissions—proof of the trust we've earned and the efficiency our platform delivers year after year.' — Ramesh Padri, VP of Product Delivery at Simplify Healthcare. 'Managing the full Medicare Advantage lifecycle—from bids to digital delivery—makes Benefits1™.Medicare truly stand out in helping Payers drive value and improve member experiences.' — Tasneem Chital, VP of Government Markets at Simplify Healthcare. Industry Leadership Through Customer Focus As healthcare organizations face increasing operational and regulatory challenges, Benefits1™.Medicare offers an effective solution that simplifies workflows while driving greater organizational efficiency. 'This milestone reflects our long-standing commitment of partnering with health plans to successfully manage bid submissions. We bring the full stack partnership experience — people, thought leaders, product, and technology — towards delivering a superior bid submission experience for our customers.' — Nirnay Patel, EVP & GM of Benefits1™ at Simplify Healthcare. About Simplify Healthcare Simplify Healthcare powers connected benefits and provider journeys for Payers through a scalable, enterprise-grade, secure, compliant, and configurable cloud-based software platform — Simplify Health Cloud™. We offer highly scalable, technology-centered document and translation management services to Payers through Simplify Docs™. We also empower industries with AI-native SaaS solutions designed to build and deploy digital solutions faster, better, and with embedded AI through SimplifyX™.

Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader
Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader

Yahoo

timean hour ago

  • Yahoo

Simplify Healthcare's Benefits1™.Medicare Drives Over 30% of Nationwide PBP Submissions to CMS, Marking Over 7 Years as a Trusted Industry Leader

AURORA, Ill., June 06, 2025--(BUSINESS WIRE)--Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, proudly announces that its flagship platform, Benefits1™.Medicare, played a key role once again in streamlining over 30% of Medicare Advantage (MA) Plan Benefit Package (PBP) submissions to the Centers for Medicare & Medicaid Services (CMS) this year. This milestone highlights the platform's transformative impact on benefit plan management and its integral role in supporting Payers across the nation. Benefits1™.Medicare continues to be the industry leader, enabling large-scale CMS bid submissions successfully for over 7 years, while also importing data seamlessly from the CMS-PBP software. Designed to handle the complexities of bid submission and accessible immediately (benefit updates can be started at any time independent of HPMS releases), the platform continues to set the standard for speed, accuracy, and compliance in PBP submissions with its seamless integration, robust reporting, global data updates, secure user roles, workflow automation and audit tracking capabilities. "Our customers relied on Benefits1™.Medicare to streamline over 30% of nationwide PBP submissions—proof of the trust we've earned and the efficiency our platform delivers year after year." — Ramesh Padri, VP of Product Delivery at Simplify Healthcare. "Managing the full Medicare Advantage lifecycle—from bids to digital delivery—makes Benefits1™.Medicare truly stand out in helping Payers drive value and improve member experiences." — Tasneem Chital, VP of Government Markets at Simplify Healthcare. Industry Leadership Through Customer Focus As healthcare organizations face increasing operational and regulatory challenges, Benefits1™.Medicare offers an effective solution that simplifies workflows while driving greater organizational efficiency. "This milestone reflects our long-standing commitment of partnering with health plans to successfully manage bid submissions. We bring the full stack partnership experience — people, thought leaders, product, and technology— towards delivering a superior bid submission experience for our customers." — Nirnay Patel, EVP & GM of Benefits1™ at Simplify Healthcare. About Simplify Healthcare Simplify Healthcare powers connected benefits and provider journeys for Payers through a scalable, enterprise-grade, secure, compliant, and configurable cloud-based software platform — Simplify Health Cloud™. We offer highly scalable, technology-centered document and translation management services to Payers through Simplify Docs™. We also empower industries with AI-native SaaS solutions designed to build and deploy digital solutions faster, better, and with embedded AI through SimplifyX™. View source version on Contacts Simplify HealthcarePhone: (844) 720-6678Email: info@ Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store